National Health Research Institutes, Taiwan Clinical Trial Pipeline: 35 Active Trials, 1 Changes This Month

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Minor

Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma

Trial completed

National Health Research Institutes, TaiwanPhase 1 NCT04688151 Registry history of NCT04688151 on ClinicalTrials.gov (opens the registry)

Updated Sep 17, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First posted	Trial	Phase	Status
2026-10-02	NCT07855874 NHRI Intelligent Voice Interactive Platform for High-Quality Community Living Among Older…		Recruiting
2026-09-23	NCT07835698 The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients		Not Yet Recruiting

Active trials by phase

Phase 1		1
Phase 1/2		4
Phase 2		4

Not charted: 26 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 35

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT06981637	Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue…	Advanced Soft Tissue Sarcoma	Recruiting	2026-07-02
NCT05026905	A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV…	Phase II, Open-label, Parallel 2-arm, Multi-center	Active, Not Recruiting	2026-07-02
NCT05170438	Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to…	Advanced Biliary Tract Cancer	Active, Not Recruiting	2026-07-02
NCT07151326	Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy	Hepatocellular Carcinoma (HCC)	Not Yet Recruiting	2025-09-03
Phase 1/2
NCT05048901	Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors	Neuroendocrine Tumors,Gastroenteropancreatic	Recruiting	2026-04-09
NCT05927857	Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second…	Metastatic Gastric Adenocarcinoma	Recruiting	2026-04-09
NCT05385861	Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET	GEP-NET	Enrolling by Invitation	2025-08-15
NCT04856137	A Phase I/II Study of Diffuse Large B-cell Lymphoma	Refractory Diffuse Large B-cell Lymphoma	Not Yet Recruiting	2021-04-23
Phase 1
NCT07782346	Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid…	Advanced Solid Malignancies	Not Yet Recruiting	2026-08-26
Not applicable
NCT07855874	NHRI Intelligent Voice Interactive Platform for High-Quality Community Living Among Older…	Aging	Recruiting	2026-10-02
NCT07579832	Quantitative Monitoring of Disability Care Quality for Long-Term Care Facilities 2	Disabled Persons	Recruiting	2026-08-21
NCT07540117	Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults	Aging	Recruiting	2026-04-23
NCT06271200	Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)	Metabolic Syndrome	Recruiting	2026-04-08
NCT07351877	Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults…	Aging	Recruiting	2026-01-20
NCT07330635	Chronic Wounds and Blood Circulation Detection	Aging	Recruiting	2026-01-09
NCT07186023	Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan…	Late-Life Adults	Recruiting	2025-09-22
NCT07835698	The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients	Breast Cancer	Not Yet Recruiting	2026-09-23
NCT07764107	Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy…	Insomnia	Not Yet Recruiting	2026-08-21
NCT04180072	Atezolizumab Plus Bevacizumab With HCC and HBV Infection	Carcinoma, Hepatocellular	Active, Not Recruiting	2026-04-09
NCT07177365	Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized…	Generalized Anxiety Disorder (GAD)	Not Yet Recruiting	2025-09-22
Not specified
NCT05522881	The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan	Oropharyngeal Squamous Cell Carcinoma	Recruiting	2026-07-02
NCT07541547	Adult Disease Risk Prediction Using Wearables, Hearing, and Health Data	Chronic Disease	Recruiting	2026-04-21
NCT06127446	The Registry of Genetic Alterations of Taiwan Ovarian Cancer	Ovarian Cancer	Recruiting	2026-04-09
NCT04849481	The Research Plan of Taiwan Precision Medicine	Non-small-cell Lung Cancer	Recruiting	2026-04-08
NCT07151365	Plant-based Diets and Healthy Aging	Healthy Aging	Recruiting	2026-04-08

See all 35 active National Health Research Institutes, Taiwan trials with filters →

Disease areas by active trials, top 10 of 18

Head & Neck Cancer (3) · Liver Cancer (3) · Cholangiocarcinoma (2) · Depression (2) · Thyroid Cancer (2) · Anxiety (1) · Breast Cancer (1) · DLBCL (1) · Esophageal Cancer (1) · Gastric Cancer (1)

National Health Research Institutes, Taiwan clinical trial pipeline

What changed in the last 30 days

Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS…Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma

New trial filings, last 30 days

Active trials by phase

Active trials top 25 of 35

Disease areas by active trials, top 10 of 18

Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma